NOD2 receptor and the cytosolic protein kinase RIPK2 regulate NF-kB and MAP kinase signaling during bacterial infections, but the role of this immune axis during viral infections has not been addressed. We demonstrate that Nod2 −/− and Ripk2 −/− mice are hypersusceptible to infection with influenza A virus. Ripk2 −/− cells exhibited defective autophagy of mitochondria (mitophagy), leading to enhanced mitochondrial production of superoxide and accumulation of damaged mitochondria, which resulted in greater activation of the NLRP3 inflammasome and production of IL-18. RIPK2 regulated mitophagy in a kinase-dependent manner by phosphorylating the mitophagy inducer ULK1. Accordingly, Ulk1 −/− cells exhibited enhanced mitochondrial production of superoxide and activation of caspase-1. These results demonstrate a role for NOD2-RIPK2 signaling in protection against virally triggered immunopathology by negatively regulating activation of the NLRP3 inflammasome and production of IL-18 via ULK1-dependent mitophagy.
A r t i c l e s Seasonal influenza A virus (IAV) epidemics are a major cause of morbidity and economic loss, with annual mortality rates estimated in the 9,000-45,000 range for the United States alone 1 . In addition, global pandemics of IAV strains with new antigens that emerge from avian and domestic swine reservoirs can result in deaths of millions. The catastrophic 1918 H1N1 pandemic was characterized by an unusually high incidence of rapid lethality in otherwise healthy young adults 2 . More recently, similar pathological profiles have been documented for infections caused by the highly virulent avian H5N1 IAV strains 3, 4 . In both humans and animal models, infections with these highly pathogenic strains were characterized by rapid onset of a proinflammatory 'cytokine storm' that damaged lung epithelium, resulting in edema and hemorrhage. Relative to the host responses induced by low-pathogenicity influenza viruses, host responses to infection with the 1918 H1N1 or highly pathogenic H5N1 viruses are associated with markedly greater neutrophil and macrophage infiltration and elevated amounts of cytokines and chemokines, including IL-1β, IFN-γ and tumor necrosis factor (TNF) [4] [5] [6] . Thus, it is increasingly clear that overt inflammation during IAV infection contributes substantially to morbidity and mortality.
Signaling pathways that regulate the innate immune response to IAV infection are now being defined, with obvious roles for the endocytic Toll-like receptors TLR3 (ref. 7) and TLR7 (ref. 8) , and the cytosolic receptor RIG-I (ref. 9) . Recently, members of the Nod-like receptor (NLR) family have also been shown to recognize IAV in the cytosolic compartment [10] [11] [12] . NLRP3 detects IAV infection through multiple mechanisms, including ion flux generated by the virusencoded M2 ion channel 11 and via the recognition of viral RNA 10, 13 . These signals serve to activate the inflammasome, a macromolecular complex consisting of caspase-1, the adaptor protein ASC and NLRP3 (ref. 14) . Inflammasome activation leads to the cleavage of many substrates, including pro-IL-1β and pro-IL-18, and the initiation of the proinflammatory form of cell death known as pyroptosis 15 .
Autophagy is a cellular process where cytoplasmic doublemembrane vesicles are formed and engulf cytoplasmic contents. Several forms of autophagy exist, including macroautophagy, where long-lived proteins or organelles are engulfed and degraded for recycling 16 . Recently macroautophagy has been shown to be a critical modulator of inflammasome activation 17 , but it is unknown whether this is applicable during viral infection. Another subset of the autophagic process is known as mitophagy, where mitochondria are specifically degraded in response to damage or developmental cues 18, 19 . Finally, xenophagy is an innate immune mechanism, where invading cytosolic pathogens are captured and degraded to prevent their spread and for antigen presentation to initiate adaptive immunity 20,21 . A r t i c l e s RIPK2 (also known as RIP2 or RICK) is a critical mediator of inflammatory responses to bacterial infections, where it is activated by the NLRs NOD1 and NOD2. RIPK2 is involved in the induction of xenophagy in response to bacterial infections 20, 22, 23 . Furthermore, the sensing of bacterial peptidoglycan components activates the NOD1-NOD2-RIPK2 axis and signals through the transcription factor NF-κB and through MAP kinase (MAPK) to activate inflammatory cells and to promote secretion of proinflammatory cytokines and chemokines 24 . Although NOD2 regulates production of type I interferon during viral infections independently of RIPK2 (refs. 25, 26) , putative roles of RIPK2 during IAV infection have not been determined. Here we demonstrate that Ripk2 −/− mice are hypersusceptible to IAV infection. RIPK2 dampens activation of the inflammasome and secretion of IL-18, which contribute critically to disease progression. Mechanistically, increases in the production of IL-18 and activation of the inflammasome are a consequence of defective induction of mitophagy in IAV-infected Ripk2 −/− mice and immune cells. Finally we demonstrate that activation of the critical autophagy inducer ULK1 is lower in Ripk2 −/− cells and that Ulk1 −/− cells also exhibited greater inflammasome activation and lower mitophagy relative to wild-type controls. Our results highlight a previously unknown RIPK2-dependent signaling network that negatively regulates inflammasome activation through mitophagy during viral infection.
RESULTS

RIPK2 protects against severe IAV infection
To examine the potential role of NOD2 and RIPK2 in the immune response to IAV infection, we challenged wild-type, Nod2 −/− and Ripk2 −/− mice intranasally with the virulent influenza A/Puerto Rico/8/34 (PR8) H1N1 virus and monitored survival over time. Relative to wild-type controls, Nod2 −/− and Ripk2 −/− mice had significantly higher mortality rates ( Fig. 1a) . Although signs of pathological damage to the lungs of wild-type mice were minimal by day 2 after PR8 inoculation, lung sections of both knockout mouse lines showed marked pathological changes, characterized by greater pulmonary airway obstruction and increased cell death on days 2 and 7 after infection ( Fig. 1b-d and data not shown). Moreover, airway obstruction of IAV-infected Ripk2 −/− mice consisted mainly of neutrophils ( Fig. 1e) . Whereas neutrophil counts were elevated in the Ripk2 −/− whole lung on days 2 and 7, we observed no increases in the numbers of other myeloid cells ( Fig. 1f,g) . Despite the greater susceptibility of Ripk2 −/− mice to IAV infection, lung virus titers were comparable to those in wild-type controls (Fig. 1h) . Thus, NOD2 and RIPK2 protect against severe IAV infection, although this is not correlated with the extent of virus replication.
RIPK2 regulates IFN-g and IL-18
Given that the inflammatory response to IAV is thought to contribute to mortality 3, 4 , we investigated the role of RIPK2 in cytokine production. To this end, we collected whole lung homogenates on days 2 and 7 after intranasal challenge of wild-type and Ripk2 −/− mice with the PR8 virus and determined the extent of inflammatory mediator production by enzyme-linked immunosorbent assay (ELISA). Although RIPK2 regulates production of IL-6 and TNF during bacterial infections 27 , we observed no significant differences in the amounts of these cytokines in lungs of virus-infected wild-type and Ripk2 −/− mice ( Fig. 2a) . In contrast, IFN-γ, a known mediator of inflammation in viral immunity 28 , and IL-18 were significantly upregulated in Ripk2 −/− mice ( Fig. 2b) . Originally, IL-18 had been identified as an IFN-γ-inducing cytokine 29 , suggesting that production of IFN-γ might be consequential to more IL-18 release in IAV-infected Ripk2 −/− mice. Previous studies have shown the chemokines CCL2 (MCP-1) and CXCL10 (IP-10) are induced by IL-18 and IFN-γ 30 
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A r t i c l e s we observed elevated production of both CCL2 and CXCL10 in IAVinfected Ripk2 −/− mice (Fig. 2c) . These results indicate that greater susceptibility to IAV infection in Ripk2 −/− mice is associated with exacerbated production of IL-18 and IFN-γ.
IL-18 antagonism in Ripk2 −/− mice improves survival
We hypothesized that the higher production of IL-18 was responsible for increased inflammation and mortality during IAV infection of Ripk2 −/− mice. To test this, we injected Ripk2 −/− mice intraperitoneally with anti-IL-18 neutralizing antibody 3 h before infection with PR8. This treatment resulted in significantly lower amounts of IL-18, IFN-γ and CCL2 in the lungs of IAV-infected Ripk2 −/− mice ( Fig. 3a) . This was followed by moderately fewer of the chemokines CXCL10, CXCL1 (KC) and CCL3 (MIP-1α) (P = 0.15, 0.30 and 0.22, respectively; Supplementary Fig. 1a ). Furthermore, IL-18 neutralization dampened virus-induced lung pathology and airway neutrophilia ( Fig. 3b,c and Supplementary Fig. 1b) , and significantly improved survival ( Fig. 3d) . These results suggest that the higher production of IL-18 drives elevated morbidity and mortality in IAV-infected Ripk2 −/− mice. To confirm the critical role of IL-18 in this process, we generated mice lacking both RIPK2 and IL-18 (Ripk2 −/− Il18 −/− mice) and challenged these mice with a lethal dose of IAV. As with Ripk2 −/− mice receiving IL-18-neutralizing antibodies, genetic ablation of IL-18 rescued the hypersensitive response of Ripk2 −/− mice; tissue neutrophil infiltration and mortality rates returned to levels comparable to those of infected wild-type mice ( Fig. 3e,f) . These results demonstrate a critical role for elevated IL-18 production increasing morbidity and mortality in IAV-infected Ripk2 −/− mice.
Immune and lung cells contribute to elevated IL-18
To identify the cellular compartments that contribute to RIPK2-mediated modulation of IL-18, we generated bone marrow chimeras that 
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A r t i c l e s selectively expressed RIPK2 in the radiation-sensitive (donor bone marrow) or radiation-resistant (recipient lung) compartments. We infected these chimeric mice intranasally with PR8 and assessed IL-18 production by immunohistochemistry and ELISA. Both Ripk2 −/− hematopoietic and non-immune (likely lung epithelial) cells contributed to higher production of IL-18 in the pulmonary tract of IAV-infected Ripk2 −/− mice (Fig. 4a,b and Supplementary Fig. 2a ).
Innate and adaptive lymphocytes are hyperactivated
We next examined the cellular populations that were responsible for the larger amounts of IFN-γ observed in Ripk2 −/− mice compared to wild-type mice. Both NK cells and CD8 + T cells isolated from PR8-infected Ripk2 −/− mice produced more IFN-γ per cell and were more highly activated, although the absolute numbers of these cells remained similar to those in wild-type mice ( Fig. 4c-f , and Supplementary Fig. 2b-d) . These results indicate that larger amounts of IL-18 in Ripk2 −/− mice subsequently lead to more production of IFN-γ from innate and adaptive cell populations.
NOD2-RIPK2 axis regulates caspase-1 activation and IL-18
NOD2 has been reported to regulate type I interferon during IAV infection 25, 26 . Although we confirmed the reported defect in the production of type I interferon after IAV infection of Nod2 −/− alveolar macrophages (P = 0.018; data not shown), Ripk2 −/− macrophages produced type I interferon (IFN-β) protein in amounts similar to those of wild-type cells (P = 0.469, data not shown), suggesting that differences in type I interferon signaling are unlikely to account for the observed hypersensitive phenotype of Ripk2 −/− mice. Similarly, we found no differences in activation of NF-κB (pIκBα) and MAPK (p-Erk) pathways in IAV-infected Ripk2 −/− bone marrow-derived dendritic cells (BMDCs; data not shown). We therefore analyzed processes directly regulating maturation of IL-18 rather than abundance of transcripts encoding IL-18. Unlike most cytokines, IL-1β and IL-18 are produced as pro-peptides that require proteolytic maturation by the cysteine protease caspase-1 to be released in their biologically active forms 31 .
Notably, both activation of caspase-1 and release of mature IL-18 were markedly greater in PR8 infected Ripk2 −/− and Nod2 −/− BMDCs compared to wild-type controls ( Fig. 5a,b ). In agreement with the observed greater caspase-1 activation, we also detected more IL-1β in Ripk2 −/− BMDCs compared to wild-type controls. We therefore reexamined lung homogenates from in vivo samples for IL-1β. However, low amounts of IL-1β likely confounded detection of differences in this cytokine in vivo (Supplementary Fig. 3a ). Next, we examined activation of caspase-1 in response to other pathogens. We observed that the X31 low-pathogenicity influenza A virus also elicited higher caspase-1 activation in Ripk2 −/− BMDCs ( Supplementary  Fig. 3b ). We also examined inflammasome activation during infection with bacteria known to activate the RIPK2 signaling pathway. Infection with Listeria monocytogenes did not augment processing of caspase-1 and production of IL-18 in Ripk2 −/− and Nod2 −/− BMDCs (Fig. 5c,d) . Enhancement of inflammasome activation by IAV in Ripk2 −/− BMDCs was dependent on NLRP3, as the NLRP3-specific inhibitor glyburide 32 significantly inhibited activation of caspase-1 and production of IL-18 ( Fig. 5e,f) . In the case of Listeria infection, the AIM2 inflammasome has a predominant role in inflammasome activation 33 . In agreement, Aim2 −/− BMDCs exhibited nearly complete impairment in caspase-1 activation after infection with Listeria (Fig. 5g) . These data indicate that enhanced activation of the NLRP3 inflammasome occurs in Ripk2 −/− BMDCs during IAV infection but not during Listeria infection, indicating that this pathway is not involved in global disregulation of inflammasome activation, but specific to the NLRP3 inflammasome. 
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A r t i c l e s RIPK2 regulates the NLRP3 inflammasome through autophagy To determine the mechanism by which RIPK2 dampens inflammasome activation, we first assessed the effect of RIPK2 overexpression on maturation of caspase-1 and release of IL-18 in transfected 293T cells. In agreement with published reports 34 , overexpressed RIPK2 interacted with caspase-1, but overexpression enhanced, rather than inhibited, processing of caspase-1 and release of IL-18 (data not shown), indicating that overexpression of RIPK2 cannot directly inhibit inflammasome activation. Because Ripk2 −/− BMDCs do not display a global defect in inflammasome activation (Fig. 5) , this suggests that RIPK2 may modulate caspase-1 indirectly in our model. In this regard, autophagy has been described to negatively regulate inflammasome activation during bacterial infections 17, 35, 36 . We therefore hypothesized that Ripk2 −/− and Nod2 −/− BMDCs might be defective in the induction of autophagy in response to IAV infection. LC3 lipidation is an important step in the formation of autophagosomes. Therefore, one method to examine autophagic activity is to examine the amount of LC3-II (lipidated form). In agreement with our hypothesis, Ripk2 −/− and Nod2 −/− BMDCs had substantially less LC3-II protein than wild-type BMDCs infected with either PR8 or X31 ( Fig. 6a and Supplementary Fig. 4a ). Turnover of autophagosomes, which results from their fusion with lysosomes, was not affected by IAV infection in wild-type or Ripk2 −/− BMDCs as treatment with the lysosomal fusion inhibitor chloroquine resulted in the expected accumulation of LC3 + puncta by immunofluorescence and LC3-II by immunoblot (Fig. 6b,c and Supplementary Fig. 4b ). Finally, we counted autophagosomes by electron microscopy and determined that after IAV infection Ripk2 −/− BMDCs had significantly fewer autophagosomes than wild-type BMDCs (P = 0.035; Supplementary  Fig. 4c-e ). To establish the potential role of autophagy induction in response to IAV infection in regulating activation of caspase-1, we compared wild-type, RIPK2-and ATG7-deficient bone marrowderived macrophages, which lack a critical component of the autophagy machinery in myeloid cells. Both RIPK2-and ATG7deficient bone marrow-derived macrophages responded to IAV infection with enhanced activation of caspase-1 relative to wild-type macrophages (Supplementary Fig. 4f) . To confirm the role of autophagy in Ripk2 −/− cells, we treated Ripk2 −/− BMDCs with rapamycin to force the induction of autophagy. After treatment with rapamycin, IL-18 production and caspase-1 activation in Ripk2 −/− BMDCs diminished to wild-type amounts (Fig. 6d,e) . We next verified the role of autophagy in vivo and found that the amount of LC3-II protein was lower in the lungs of IAV-infected Ripk2 −/− mice relative to WT controls (Fig. 6f) .
We also examined the effects of inducing autophagy in vivo with rapamycin treatment in IAV-infected Ripk2 −/− mice and observed that rapamycin treatment dampened recruitment of neutrophils and production of inflammatory cytokines in Ripk2 −/− mice (Fig. 6g,h) .
Together, these results demonstrate that RIPK2 negatively regulates inflammasome activation, inflammatory cytokine production and neutrophil recruitment by inducing autophagy in IAV-infected cells and mice.
Viral RNA genomes activate autophagy through NOD2-RIPK2 To examine the mechanism by which NOD2 and RIPK2 induce autophagy, we expressed RIPK2 and NOD2 in the presence or absence of IAV infection and determined that infection induced an interaction between RIPK2 and NOD2 (Supplementary Fig. 5a ).
Next, we determined the viral ligand that triggers NOD2-RIPK2 signaling. The cytosolic delivery of viral RNA analogs (polyriboinosinic:polyribocytidylic acid (poly (I:C)) plus the transfection reagent LyoVec) induced LC3-II conversion in a RIPK2-dependent and NOD2-dependent manner (Supplementary Fig. 5b ). However, extracellular delivery of naked poly(I:C) induced LC3-II conversion independently of the RIPK2 pathway ( Supplementary Fig. 5c ). We also transfected BMDCs with purified viral RNA genomes and determined that IAV viral RNA induces autophagy in a RIPK2-dependent manner (Supplementary Fig. 5d ). Finally, transfection of IAV viral RNA followed by treatment with ATP resulted in enhanced production of IL-18 in both Ripk2 −/− and Nod2 −/− BMDCs ( Supplementary  Fig. 5e ). These data indicate that cytosolic viral genomes activate the cytosolic NOD2-RIPK2 signaling pathway to trigger autophagy.
NOD2-RIPK2-mediated mitophagy regulates the inflammasome
In addition to preserving cellular energy stores, autophagy is linked to the removal of damaged mitochondria. Notably, mitochondrial damage and the subsequent release of reactive oxygen species (ROS) is linked to activation of the NLRP3 inflammasome 34, 37 . We thus hypothesized that defective mitophagy induction in IAV-infected RIPK2-deficient cells triggered greater inflammasome activation because of the accumulation of damaged mitochondria. To investigate this possibility, we examined mitochondrial superoxide production after IAV infection. IAV infection increased the production of mitochondrial superoxide in Ripk2 −/− and Nod2 −/− BMDCs to a markedly greater extent than in wild-type BMDCs (Fig. 7a and b c d a Influenza:
GAPDH
Casp-1 p20
Listeria: Supplementary Fig. 6a,b) . To confirm that mitochondrial damage was responsible for our observed phenotype, we examined mitochondrial superoxide during Listeria infection. Although Listeria infection generated a more robust production of superoxide compared to IAV infection, there was no difference between wild-type and Ripk2 −/− cells ( Fig. 7b and Supplementary Fig. 6c ). We also counted damaged mitochondria (disrupted cristae) using electron microscopy and determined that IAV-infected Ripk2 −/− BMDCs had a greater ratio of damaged to healthy mitochondria than did wild-type controls (Supplementary Fig. 6d) . We confirmed the role of mitophagy in our model by staining BMDCs infected with IAV or Listeria with MitoTracker Green and examined the fluorescence intensity by flow cytometry. Cells with higher geometric mean fluorescence intensity (MFI) indicate an accumulation of mitochondria. Although Ripk2 −/− cells in some experiments had more mitochondria even before infection, we observed that IAV-infected Ripk2 −/− BMDCs, but not wildtype ones, exhibited an increase in the number of mitochondria, and we did not observe this increase in Listeria-infected Ripk2 −/− cells ( Fig. 7c and Supplementary Fig. 7a-c) . We confirmed these findings by isolating DNA from BMDCs and comparing the ratio of nuclear DNA to mitochondrial DNA. Using this approach, we also determined that there were more mitochondria in IAV-infected Ripk2 −/− BMDCs compared to wild-type BMDCs (Supplementary Fig. 7d) .
As mitophagy appears to be defective in Ripk2 −/− cells, resulting in greater production of mitochondrial superoxide, we treated Ripk2 −/− BMDCs with N-acetyl cysteine (NAC), a general ROS inhibitor, and found significantly less IL-18 and caspase-1 activation relative to control-treated Ripk2 −/− BMDCs infected with IAV (Fig. 7d,e) .
We obtained similar results with the specific mitochondrial superoxide inhibitor mitoTEMPO (Fig. 7f) . To confirm the specificity of these results, we treated Ripk2 −/− Listeria-infected BMDCs with NAC. In agreement with the role for the AIM2 inflammasome in Listeria infection, we observed little or no effect of NAC treatment during Listeria infection (Supplementary Fig. 7e ). Finally, we verified directly that mitophagy was lower during IAV infection in Ripk2 −/− BMDCs compared to infected wild-type cells by staining for LC3 and mitochondria. The ratio of LC3 + puncta that localized with mitochondria, as assayed by confocal microscopy, was significantly lower in Ripk2 −/− cells compared to wild-type BMDCs (Fig. 7g) . These results indicate that the induction of mitophagy during IAV infection, which is regulated by NOD2 and RIPK2, is essential for the clearance of damaged mitochondria. In the absence of RIPK2 or NOD2, elevated production of mitochondrial superoxide enhanced activation of the NLRP3 inflammasome.
RIPK2 regulates mitophagy through its kinase activity RIPK2 has been reported to regulate autophagy through the autophagy protein ATG16L1 (refs. 22,23) . However, another group found no interaction between RIPK2 and ATG16L1 (ref. 37). To examine how RIPK2 regulates mitophagy during viral infection, we first examined the possibility that RIPK2 might interact with ATG16L1. We expressed RIPK2 and the autophagy-related protein ATG16L1 in the presence or absence of NOD2 and IAV infection. IAV infection was required for association of RIPK2, NOD2 and ATG16L1 (Supplementary Fig. 8a) . However, endogenous RIPK2 did not immunoprecipitate with ATG16L1, and we did not detect substantial colocalization of these a c 
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A r t i c l e s proteins by immunofluorescence confocal microscopy in BMDCs during IAV infection (data not shown). Although the overexpression data above suggest that the interaction with ATG16L1 may be important during IAV infection, this remains to be verified under endogenous conditions. Furthermore, an interaction between RIPK2 and ATG16L1 still does not address the upstream signaling that initiates mitophagy during infection. To begin to address the exact mechanism by which RIPK2 regulates mitophagy in our model, we examined the role of RIPK2's kinase activity during induction of mitophagy. Treatment of wild-type BMDCs with the p38 and RIPK2 inhibitor SB203580 resulted in less LC3-II conversion and more caspase-1 activation as well as greater IL-18 production (Fig. 8a,b) .
We confirmed that this effect was due to inhibition of RIPK2 by examining autophagy in p38-deficient BMDCs. p38 deficiency did not impact LC3-II conversion during IAV infection, indicating that the effect of SB203580 was mediated by inhibition of RIPK2 ( Supplementary  Fig. 8b) . Next, we examined autophagy proteins known to be activated by phosphorylation and discovered that the extent of phosphorylation of ULK1 at Ser555 was less in Ripk2 −/− BMDCs during IAV infection, although upregulation of total ULK1 was not affected (Fig. 8c) . Phosphorylation at Ser555 of ULK1 is known to be important for its activation, and ULK1 is known to have an important role in mitophagy, especially during hematopoietic development 38 . We therefore examined Ulk1 −/− BMDCs and found that they also have increased npg activation of caspase-1 after infection with IAV and this increased activation of caspase-1 was suppressed by NAC treatment (Fig. 8d) . Furthermore, Ulk1 −/− BMDCs had more mitochondrial damage and greater mitochondrial mass compared to wild-type BMDCs (Fig. 8e,f and Supplementary Fig. 8c ). Collectively, these data demonstrate that NOD2 and RIPK2 interact with each other in response to IAV RNA genomes and regulate mitophagy in a manner dependent on the kinase activity of RIPK2 and on ULK1. Mitophagy is then responsible for removing damaged mitochondria and preventing excessive activation of NLRP3 and production of IL-18 (Fig. 8g) .
DISCUSSION
Although the in vivo relevance of RIPK2-mediated signaling for immunity against bacterial pathogens has been clearly demonstrated for pathogens such as Helicobacter pylori and Listeria monocytogenes 39, 40 , the role of RIPK2 in the immune response to viral infections in vivo has not been reported to our knowledge. In addition, the involvement of RIPK2 in signaling pathways other than the regulation of NF-κB and MAP kinase has not been explored in detail.
Here we demonstrated that RIPK2 is critical for protection against IAV-induced immunopathology during IAV infection. Our results demonstrate that RIPK2 functions by negatively regulating production of IL-18 and IFN-γ in stromal and immune cells of the pulmonary tract. We identified NOD2 as the NLR acting upstream of RIPK2 in mediating protection against IAV-induced morbidity and mortality. These results thus implicate NOD2 as a key partner in additional immune signaling pathways during viral infection, beyond those previously discovered for type I interferons 25, 26 .
Although we observed elevated IL-1β in vitro by infecting BMDCs with IAV, the amount of IL-1β present in vivo was 5-10 times lower than that of IL-18. These low amounts of IL-1β in vivo likely obscured our ability to detect differences in this cytokine initially. We expect that IL-1β may also have some role in our model in vivo; however, we illustrated the importance of RIPK2-mediated dampening of IL-18 by the marked effect of IL-18-neutralizing antibodies in reducing the morbidity and mortality in Ripk2-deficient mice infected with IAV, and we confirmed this in Ripk2 −/− Il18 −/− mice. This demonstrates that excessive IL-18 production in Ripk2 −/− mice drives the majority of the immunopathology.
Immunopathology is a key factor in acute fatal IAV pneumonia in humans and in animal models infected with highly virulent IAV strains 41, 42 . Our finding that IL-18 mediates hyperinflammatory responses in Ripk2 −/− mice thus opens new possibilities for the treatment of severe IAV infections. In other disease models, elevated IL-18 has been shown to promote neutrophil infiltration, and to mediate the production of IFN-γ and chemokines (lipopolysaccharide-induced toxemia and ischemic reperfusion, respectively). Decreasing the amount of IL-18 in these experimental systems limits the extent of tissue damage and promotes survival 43, 44 . Blocking IL-18 may limit the extent of lung immunopathology in situations where IAV infection leads to extreme respiratory distress.
At the molecular level, our data show that RIPK2 dampens harmful IL-18-driven inflammatory responses against IAV by preventing excessive activation of caspase-1 through a mitophagy-mediated suppression mechanism rather than via a direct interaction with caspase-1. Multiple inflammasomes that activate caspase-1 in a pathogendependent manner have been identified. However, our previous studies had identified a critical role for the NLRP3 inflammasome in regulating production of IL-1β and IL-18 in IAV infection both in vivo and in vitro 12, 13 . Here we extended these findings by showing that RIPK2-mediated inhibition of inflammasome activation proceeds through the removal of damaged mitochondria and subsequently lower mitochondrial production of superoxide, a known activator of the NLRP3 inflammasome 35, 45 . We verified the role of the NLRP3 inflammasome in our model by treatment with the NLRP3-specific inhibitor glyburide.
Many reports differ on the mechanism by which RIPK2 regulates the induction of autophagy or xenophagy in response to bacterial infection 20, 22, 23, 37 . In fact, there are differing reports on the role of RIPK2 and ATG16L1 during bacterial infection 22, 23, 37 . Although we observed an interaction between these two proteins when they were overexpressed, we could not verify this interaction in BMDCs during IAV infection, despite the use of multiple methods and conditions. We therefore sought out other potential mechanisms by which RIPK2 could regulate autophagy. We discovered that Ripk2 −/− BMDCs had more mitochondrial damage and more mitochondrial mass, suggesting that mitophagy was defective. To identify the mechanisms involved in RIPK2-mediated mitophagy, we examined the mitophagy protein Parkin through the use of Parkin-deficient mice (Park2 −/− ). However, we did not observe any role for Parkin in our model (data not shown). In the end, we discovered that activation of ULK1 by phosphorylation at Ser555 was less in Ripk2 −/− BMDCs compared to wild-type controls. We also verified the importance of ULK1 in our model as Ulk1 −/− BMDCs phenocopied Ripk2 −/− BMDCs with regard to mitochondrial damage and inflammasome activation. Our findings highlight a signaling pathway in which NOD2 and RIPK2 respond to viral infection by promoting ULK1 phosphorylation and inducing mitophagic responses that dampen inflammasome activation and IL-18 production. Although it is clear that Ripk2 deficiency resulted in less ULK1 phosphorylation, it is not clear whether RIPK2 directly phosphorylates ULK1 or whether there are other intermediates that are regulated by RIPK2, which subsequently activate ULK1.
Recently, autophagy has been shown to directly clear inflammasomes from activated cells, thus modulating inflammation 17 . However, we did not observe any role for autophagy in our system during Listeria infection dependent on the AIM2 inflammasome, suggesting that global degradation of the inflammasome by macroautophagy is likely not important in our model. Furthermore, virus replication was not affected in our model, suggesting that xenophagy also does not have a substantial role. Therefore, our data are the first to our knowledge to demonstrate that NOD2-RIPK2 signaling can regulate mitophagy specifically during viral infection and to demonstrate the physiological relevance of this pathway in controlling pulmonary inflammation in vivo. Notably, Rikp2 −/− cells had slightly higher basal mitochondrial mass and numbers of damaged mitochondria. These data may indicate a role for Ripk2 in the steady-state regulation of mitophagy. In the future it will be of interest to examine whether this can exacerbate other non-infectious diseases where mitochondrial damage or metabolic stresses are known to be factors. In all, our findings demonstrate that NOD2-RIPK2 signaling is involved in the recognition of a wider variety of pathogens than previously thought, and we determined that RIPK2 can regulate ULK1 mediated mitophagy. Finally, our results provide a unifying principle by linking NOD2-RIPK2 signaling, autophagy or mitophagy, and inflammasome-IL-18 production together, suggesting that this pathway is a critical regulatory mechanism for preventing overt inflammation under certain disease conditions.
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